Zusammenfassung
Moderne bildgebende Verfahren ermöglichen die detaillierte Untersuchung von Struktur und Funktion des Gehirns bei Patienten mit idiopathischem Parkinson-Syndrom (IPS). Neben den etablierten Methoden wurden in den letzten Jahren neuartige MRT-Verfahren entwickelt und zur Bearbeitung wissenschaftlicher Fragestellungen eingesetzt. Dabei steht die Untersuchung verschiedener Aspekte von Hirngewebseigenschaften (MR-Relaxometrie, SWI, DWI, DTI, VBM) sowie der zerebralen Perfusion und Hirnaktivität (ASL, fcMRT) im Vordergrund des Interesses. Neben der Aufklärung der Pathophysiologie des IPS sind diese MRT-Methoden möglicherweise auch zur Untersuchung der Progressionsdynamik der Erkrankung sowie des Einflusses therapeutischer Interventionen geeignet. Daneben könnten sie möglicherweise zu einer valideren differenzialdiagnostischen Zuordnung der Parkinson-Syndrome beitragen.
Summary
Brain imaging enables the investigation of brain morphology and function in patients with Parkinson’s disease (PD). Innovative magnetic resonance imaging (MRI) techniques have recently been established as a new research tool in PD. They are based on the investigation of neuronal tissue properties (MR relaxometry, SWI, DWI, DTI, VBM) and of cerebral perfusion and neuronal activity (ASL, fcMRI). Besides a better understanding of the pathophysiology of PD, these innovative MR techniques might be suitable for measuring progression of PD and the effect of therapeutic interventions on brain functioning. In the clinical setting, they could help to advance the differential diagnosis of parkinsonian disorders.
Literatur
Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66(1):259–267
Baudrexel S, Nürnberger L, Rüb U et al (2010) Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson’s disease. Neuroimage 51(2):512–520
Baudrexel S, Witte T, Klein JC et al (2010) Subthalamic-cortical resting state (fMRI-) functional connectivity is increased in early Parkinson’s disease. 14th international congress of Parkinson’s disease and movement disorders, Buenos Aires. Abstract no. 576
Baudrexel S, Volz S, Preibisch C et al (2009) Rapid single-scan T2*-mapping using exponential excitation pulses and image-based correction for linear background gradients. Magn Reson Med 62(1):263–268
Behrens TE, Woolrich MW, Jenkinson M et al (2003) Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 50(5):1077–1088
Berg D (2007) Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson’s disease: implications for idiopathic and monogenetic forms. Neurochem Res 32(10):1646–1654
Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34(4):537–541
Borghammer P, Ostergaard K, Cumming P et al (2010) A deformation-based morphometry study of patients with early-stage Parkinson’s disease. Eur J Neurol 17(2):314–320
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211
Brown P (2003) Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson’s disease. Mov Disord 18(4):357–363
Burton EJ, McKeith IG, Burn DJ et al (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127(4):791–800
Detre JA, Wang J, Wang Z, Rao H (2009) Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Curr Opin Neurol 22(4):348–355
Dexter DT, Carayon A, Javoy-Agid F et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953–1975
Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283–2301
Haacke EM, Mittal S, Wu Z et al (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30(1):19–30
Hattingen E, Magerkurth J, Pilatus U et al (2009) Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson’s disease. Brain 132:3285–3297
Helmich RC, Derikx LC, Bakker M et al (2009) Spatial remapping of cortico-striatal connectivity in Parkinson’s disease. Cereb Cortex 20(5):1175–1186
Hotter A, Esterhammer R, Schocke MF, Seppi K (2009) Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 24(Suppl 2):711–720
Huang C, Tang C, Feigin A et al (2007) Changes in network activity with the progression of Parkinson’s disease. Brain 130(7):1834–1846
Jubault T, Brambati SM, Degroot C et al (2009) Regional brain stem atrophy in idiopathic Parkinson’s disease detected by anatomical MRI. PLoS One 4(12):e8247
Le Bihan D (2003) Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4(6):469–480
Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373(9680):2055–2066
Ma Y, Huang C, Dyke JP et al (2010) Parkinson’s disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30(3):505–509
Ma Y, Tang C, Spetsieris PG et al (2007) Abnormal metabolic network activity in Parkinson’s disease: test-retest reproducibility. J Cereb Blood Flow Metab 27(3):597–605
Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70(16, 2):1411–1417
Menke RA, Scholz J, Miller KL et al (2009) MRI characteristics of the substantia nigra in Parkinson’s disease: a combined quantitative T1 and DTI study. Neuroimage 47(2):435–441
Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30(2):232–252
Nagano-Saito A, Washimi Y, Arahata Y et al (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64(2):224–229
Ordidge RJ, Gorell JM, Deniau JC et al (1994) Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 32(3):335–341
Preibisch C, Deichmann R (2009) Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles. Magn Reson Med 61(1):125–135
Robinson S, Basso G, Soldati N et al (2009) A resting state network in the motor control circuit of the basal ganglia. BMC Neurosci 10:137
Vaillancourt DE, Spraker MB, Prodoehl J et al (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72(16):1378–1384
Wild EJ, Fox NC (2009) Serial volumetric MRI in Parkinsonian disorders. Mov Disord 24(Suppl 2):S691–S698
Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 89(1):212–216
Wu T, Wang L, Chen Y et al (2009) Changes of functional connectivity of the motor network in the resting state in Parkinson’s disease. Neurosci Lett 460(1):6–10
Yoshikawa K, Nakata Y, Yamada K, Nakagawa M (2004) Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 75(3):481–484
Zhang D, Raichle ME (2010) Disease and the brain’s dark energy. Nat Rev Neurol 6(1):15–28
Zhang J, Zhang Y, Wang J et al (2010) Characterizing iron deposition in Parkinson’s disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 1330:124–130
Interessenskonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baudrexel, S., Klein, J., Deichmann, R. et al. Innovative MRT-Verfahren bei idiopathischem Parkinson-Syndrom. Nervenarzt 81, 1180–1188 (2010). https://doi.org/10.1007/s00115-010-3023-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-010-3023-7
Schlüsselwörter
- Magnetresonanztomographie
- Idiopathisches Parkinson-Syndrom
- Magnetresonanzrelaxometrie
- Diffusionsgewichtete Bildgebung
- Arterial spin labeling